Viewing nowMephigril Tablets (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

MFDS item code 200300200 · Notified 2003.08.14 · Insurance code 644900950
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to enhance blood sugar control in patients with type 2 diabetes. It can be administered alone as an adjunct to dietary and exercise therapy, and in cases where blood sugar control is insufficient, it may be used in combination with insulin or metformin. In particular, when blood sugar control is difficult with sulfonylureas or metformin monotherapy, this medication can be used in conjunction to increase effectiveness. It assists patients in managing their blood sugar and improving symptoms of diabetes.
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medication is taken orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, little additional benefit is seen with doses above 4 mg, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider using insulin or another oral antidiabetic medication in combination. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's need for this medication may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral glucose-lowering medication to this medication There is no exact dose equivalence between this medication and other oral glucose-lowering medications. When switching from another oral glucose-lowering medication to this medication, it is recommended that the method described under Initial dose be followed. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medication should be taken into account. 4) Dose monitoring While taking this medication, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by consuming sugar immediately. Hypoglycemia may recur even after it has been successfully managed initially during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medication and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medication once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medication, adding metformin may be considered. Clinical information has been published on combination therapy with metformin and other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medication is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medication. However, efforts should be made to determine the minimum effective dose of each medication for blood glucose control. There is a risk of hypoglycemia with concomitant use of this medication and metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a coma. Furthermore, patients who have had allergic reactions to this medication or to sulfonylureas or sulfonamides should not be administered this medication. There is no experience with this medication in patients with severely impaired liver or kidney function, and switching to insulin therapy is recommended in such cases. It is safer not to use this medication in pregnant women or those who may become pregnant, as well as in breastfeeding women. Patients with severe infections, pre- and post-surgery, or severe trauma should consider insulin therapy, and care should be taken in cases of gastrointestinal disorders such as diarrhea or vomiting due to the risk of hypoglycemia. During the first week of treatment, the risk of hypoglycemia is high, so blood sugar should be closely monitored, particularly in elderly patients, those with poor nutritional status or irregular meal intake, excessive exercise, carbohydrate intake imbalances, frequent alcohol use, and patients taking other medications. Symptoms of hypoglycemia can manifest in various ways including headache, severe hunger, nausea, fatigue, confusion, drowsiness, loss of consciousness, etc., so if these symptoms occur, immediate intake of sugar or consultation with medical personnel is advised. This medication lowers blood sugar, thus it should be taken with regular meals, exercise, and weight management, and if blood sugar control is inadequate, treatment methods should be adjusted after consultation with a doctor. When taken with other medications, interactions may occur; therefore, if you are taking other medications, be sure to inform your healthcare professional. In case of overdose, severe hypoglycemia may occur, requiring immediate emergency treatment, and treatments such as inducing vomiting or intravenous glucose may be necessary. This medication has not established safety and effectiveness in children, and dose adjustment is needed for elderly patients due to decreased kidney function. Lastly, this medication must be stored in its original container and kept out of reach of children, and if any adverse reactions occur while taking this medication, immediate consultation with medical personnel is necessary.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This will help preserve the efficacy and safety of the medication for a longer duration.
Green rectangular tablets
100 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.